Apyx Medical Corporation (APYX)
NASDAQ
Real-time Data
01:30 PM
Day's Range
3.0952 wk Range
1.70Overview - APYX - Apyx Medical Corporation
Key Statistics
Valuation
Enterprise Value
143.86M
P/E (Trailing)
‪-11.51‬
P/E (Forward)
‪-12.17‬
PEG Ratio
‪0.51‬
Price / Sales (TTM)
‪2.26‬
Price / Book
‪12.41‬
EV / EBITDA
‪-52.22‬
Profitability
Gross Margin
‪63.88%‬
Profit Margin
‪-14.78%‬
Operating Margin
‪-13.00%‬
Return on Assets
‪-3.70%‬
Return on Equity
‪-90.69%‬
Ownership
Shares Outstanding
42.11M
Float
30.49M
Short % of Shares Outstanding
‪0.68%‬
Held by Insiders
‪13.54%‬
Held by Institutions
‪50.58%‬
Price stats
Beta
‪1.35‬
50-Day Avg
‪4.00‬
200-Day Avg
‪3.85‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 6.60‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - APYX - Apyx Medical Corporation
Peers - APYX - Apyx Medical Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - APYX - Apyx Medical Corporation
About
Apyx Medical Corporation is an advanced energy technology company specializing in the design, development, and manufacturing of electrosurgical equipment and medical devices. The company is best known for its proprietary helium plasma technology, marketed as Renuvion in the cosmetic surgery market and J-Plasma in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
